Home » Devicemakers With Warnings Wait for Closeout Letters
Devicemakers With Warnings Wait for Closeout Letters
February 15, 2010
Nearly six months after the U.S. Food and Drug Administration (FDA) began its closeout letter program, the agency has issued only one letter for a medical
product, leaving companies wondering when they can expect to receive the official stamp of approval that clears them of concerns raised in warning letters.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor